Search

23 Oct 2020: This course is designed to help University staff understand potential problems associated with expert witness work and how to avoid them. Read more here.

18 Dec 2020: The Postdoc Business Plan Competition has been won by GlycoVue, which is pioneering a solution for diabetes self-management.

23 Oct 2020: The programme aims to assist Colombia as it transitions from a resource-based economy to one based on science, innovation and entrepreneurship. Read more.

23 Oct 2020: Sir Ranulph was awarded the Sultan of Oman’s Bravery Medal in 1970, the Explorers Club of New York Medal in 1983, the Royal Scottish Geographical Society’s Livingstone Gold Medal ... His new book came out last year – Mad Dogs and Englishmen –

23 Oct 2020: However, HB-LEDs are currently prohibitively expensive to manufacture, making the retail price of these new devices too high for widespread uptake.

23 Oct 2020: Dr Robert Brady. CIC is a new investor in the latest round; it was established by Cambridge Enterprise as a University affiliated fund to provide long-term, follow-on capital to ... Now we have grown our international sales, with most of our customers in

23 Oct 2020: The new plant will be used to showcase Enval’s technology to potential customers across the waste sector.

23 Oct 2020: The Financing Innovation conference aims to highlight the quality of British companies, the UK research base and encourage financial backers.

23 Oct 2020: Share:. Researchers at the University of Cambridge have developed a new technique which could significantly increase success rates of pregnancies and reduce the frequency of multiple pregnancies associated with in vitro

23 Oct 2020: It was one of 10 companies named as a 2014 New Energy Pioneer by Bloomberg New Energy Finance at a ceremony in New York City earlier this year. ... e-stack systems are operating in more than 65 different buildings across the UK, ranging from retail

23 Oct 2020: 7 November 2011. Using sub-nanometre cages to identify molecules. Share:. Reliable and accurate single-molecule medical diagnosis is a step closer to reality with the development a new technique by

23 Oct 2020: The objective of the multi-million FRISBEE (Food Refrigeration Innovations for Safety, consumers Benefit, Environmental impact and Energy optimization along the cold chain in Europe) project is to provide new tools, ... awareness and uptake of our

23 Oct 2020: Share:. Cambridge Enterprise sister organisation Cambridge Innovation Capital plc (CIC) has led a $14 million Series B funding round in Undo, a pioneer in the development of new software debugging technologies. ... Undo is setting a new standard in

23 Oct 2020: James Sabry, M.D., Ph.D., Senior Vice President and Global Head of Genentech Partnering, said: “We believe that the microbiome represents a new paradigm in biomedicine both for understanding ... We have chosen to collaborate with Microbiotica because

23 Oct 2020: At the Cambridge News and Cambridge Business magazine Business Excellence Awards, Aveva, which was spun-out of the University in the 1960s and is now a billion-pound business, was named

23 Oct 2020: This year, the company opened a new North American headquarters near Washington, DC, was named to the Sunday Times tech Track 100 list for the second consecutive year, and won in ... The throughput and data quality of Illumina’s sequencers enable us to

23 Oct 2020: The Technology Transfer Offices (TTOs) of Cambridge, Edinburgh, Imperial, Oxford, Manchester and UCL have collaborated to produce a briefing paper.

23 Oct 2020: Lynparza is the first representative of a new class of medicines that blocks the action of proteins called PARP. ... The Agency is actively supporting the development of medicines with new modes of action in areas of unmet medical need.

23 Oct 2020: In the new trial, running until July 2013, children stay overnight at the CRF with their parents. ... Fundraising is currently under way to enable an extension to be built next year, to accelerate the development of effective new treatments and

23 Oct 2020: 24 April 2013. Horizon Discovery announces collaboration with AstraZeneca. Share:. Horizon Discovery has forged a research and licensing deal with AstraZeneca to find new cancer drug targets. ... AstraZeneca has a proven track record of collaborating

25 Nov 2020: The joint working group will report its findings to the President’s office this summer with the aim of having a new IP policy rolled out in the autumn.

23 Oct 2020: More than 90% of Horizon’s sales are currently made into markets outside of the UK, including the USA, Australia, New Zealand, Japan and Singapore.

23 Oct 2020: The funding will support improvement of the Company’s core technology platforms, a strengthening of its IP position, and expansion into new disease areas outside of its historical cancer focus. ... The new directors join Dr Jonathan Milner, who was

23 Oct 2020: as well as opening up potential new and exciting markets in data-centres and optical computing. ... networks as well as opening up potential new and exciting markets in data-centres and optical computing.’.

23 Oct 2020: CMR has closed its Series A funding round, raising a further $26 million from CIC and other existing investors LGT Global Invest, Escala Capital and ABB Technology Ventures, together with new ... I’m pleased to report this significant progress and

23 Oct 2020: The composition of the expert panel is created to be broadly representative of the global cleantech community, and includes pioneers, leaders, veterans, and new entrants in cleantech resulting in a list ... Bryn Parry, CEO of Amantys comments, “For a

23 Oct 2020: The new chair, which will based at Cambridge’s Department of Computer Science and Technology, will build on the University’s strengths in computer science and engineering and will be a ... Our researchers are not only developing these new technologies

23 Oct 2020: the University of Cambridge), raising a combined £40 million to support the translation of ground-breaking academic science from within these universities into innovative new medicines for a broad range of

23 Oct 2020: There were five transition steps Nick Haan took from science to business that have led to the successful and growing company BlueGnome. Read more here.

23 Oct 2020: Given its lack of capital and the difficulty of pioneering a brand new concept and technology, the company developed a “corner store” mentality. ... New product improvements came thick and fast and 1992 saw the launch of the DC-1 Declicker, the

23 Oct 2020: Dr Elaine Loukes said: “We are delighted to be supporting this new company and believe that this sensor offers unique advantages in many applications with the triad of benefits; ultra-sensitivity,

23 Oct 2020: Cambridge CMOS Sensors has patented a microsytem technology that involves new types of silicon-on-insulator (SOI) complementary metal-oxide-semiconductor (CMOS) heatersfor application in microsensors.

23 Oct 2020: FlexEnable, the flexible organic electronics company, is showcasing a full colour, conformable organic LCD (OLCD) at Mobile World Congress 2016. Read more.

23 Oct 2020: Nuaire has teamed up with natural ventilation expert Breathing Buildings to offer customers a full range of both powered and natural ventilation systems.

23 Oct 2020: ANSYS, the global leader in engineering simulation software, announced today that it has acquired Granta Design, the premier provider of materials information technology. Terms of the acquisition have not been disclosed.

23 Oct 2020: This drug has real potential to become a new, disease-modifying therapy for patients suffering from pulmonary arterial hypertension.

23 Oct 2020: Morphogen-IX Ltd, a spin-out from the University of Cambridge focused on the development of bone morphogenetic proteins (BMPs) for the treatment of...

23 Oct 2020: The Cleantech list is a three year-old joint venture between the Guardian and the Cleantech Group. Read more here.

23 Oct 2020: PneumaScan, a device developed by PneumaCare Limited, came out on top in the respiratory category of the Medical Futures Innovation Awards. Read more here.

23 Oct 2020: He leads a translational research group on development of new therapeutics for cardiopulmonary disease. ... For the past 25 years he has led a bench-to-bedside programme investigating the molecular basis of PAH and evaluating new treatments.

23 Oct 2020: of Cambridge and within the Cambridge Cluster and to expand the CIC team to capitalise on its strong inflow of new investment opportunities. ... We thank our existing shareholders for their continued support and welcome our new shareholders with great

23 Oct 2020: Cambridge, Edinburgh, Imperial, Oxford, Manchester and UCL have collaborated to produce a briefing paper: Golden Shares & Anti-dilution Provisions.

23 Oct 2020: Dr Frank Craig has been recruited as CEO, and the investment from the Discovery Fund will support the new company as it searches for its first clients and seeks additional funding,

23 Oct 2020: The challenge for government and the London financial markets is how to realise the economic benefits of these new industries for the UK.”. ... The £7 billion in science funding, the biggest sustained programme of investment in new science capital ever

23 Oct 2020: Two University spin-out companies have been included in the tech track 100 report. Read more here.

23 Oct 2020: The grant will be used to fund the development of new X-MANTM cell-lines that incorporate new predictive biomarkers of drug responses determined by the consortia’s profiling of large ... These cell lines will be owned by Horizon, which forms part of

23 Oct 2020: Eight19 is developing a new generation of low-cost, flexible plastic solar cells that have the potential to dramatically reduce the manufacturing cost and increase the throughput of solar technology, to

23 Oct 2020: Commenting on the agreement, BlueGnome CEO Nick Haan said, “Time to market is a major issue for new laboratories that wish to establish and evolve their microarray-based services. ... New ClearHyb instruments may be ordered immediately, with the first

23 Oct 2020: We believe the rAAV program has potential as a new therapeutic option for the treatment of normal refractory glaucoma through an intraocular pressure (IOP)-independent mechanism.

23 Oct 2020: There will be a special emphasis on ‘Innovation and Entrepreneurship across the University’ in several sessions of the programme, highlighting the ‘Spin-off Phenomenon’, and ‘Case Studies of New Europe Champions.’.